Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Market Cap : 7.337M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 7.337M |
| November 12, 2026 | 6.907M |
| November 11, 2026 | 7.668M |
| November 10, 2026 | 7.734M |
| November 09, 2026 | 7.502M |
| November 06, 2026 | 7.436M |
| November 05, 2026 | 6.891M |
| November 04, 2026 | 6.726M |
| November 03, 2026 | 6.660M |
| November 02, 2026 | 6.015M |
| October 30, 2026 | 5.767M |
| October 29, 2026 | 6.230M |
| October 28, 2026 | 5.453M |
| October 27, 2026 | 5.321M |
| October 26, 2026 | 4.825M |
| October 23, 2026 | 5.090M |
| October 22, 2026 | 4.941M |
| October 21, 2026 | 4.66M |
| October 20, 2026 | 4.379M |
| October 19, 2026 | 4.296M |
| October 16, 2026 | 4.726M |
| October 15, 2026 | 4.941M |
| October 14, 2026 | 4.66M |
| October 13, 2026 | 4.627M |
| October 12, 2026 | 5.404M |
| Date | Value |
|---|---|
| October 09, 2026 | 5.486M |
| October 08, 2026 | 5.288M |
| October 07, 2026 | 5.718M |
| October 06, 2026 | 5.354M |
| October 05, 2026 | 4.577M |
| October 02, 2026 | 4.759M |
| October 01, 2026 | 5.106M |
| September 30, 2026 | 5.205M |
| September 29, 2026 | 5.172M |
| September 28, 2026 | 5.329M |
| September 25, 2026 | 5.420M |
| September 24, 2026 | 5.569M |
| September 23, 2026 | 5.346M |
| September 22, 2026 | 5.321M |
| September 21, 2026 | 5.660M |
| September 18, 2026 | 5.354M |
| September 17, 2026 | 5.437M |
| September 16, 2026 | 5.114M |
| September 15, 2026 | 5.304M |
| September 14, 2026 | 5.866M |
| September 11, 2026 | 6.560M |
| September 10, 2026 | 6.693M |
| September 09, 2026 | 10.91M |
| September 08, 2026 | 15.48M |
| September 04, 2026 | 23.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Target Group, Inc. (Canada) | 0.5553M |
| XORTX Therapeutics, Inc. | 1.904M |
| NervGen Pharma Corp. | 200.06M |
| Milestone Pharmaceuticals, Inc. | 64.74M |
| Appili Therapeutics, Inc. | 0.2647M |
Market Cap Related Metrics
| PS Ratio | 34.40 |
| Price to Book Value | 1.548 |
| Price | 4.44 |
| Earnings Yield | -118.9% |